Browsing by Author "Novaković, Tatjana (24352838100)"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication COVID-19 vaccination predictors among people with mental disorders(2024) ;Novaković, Emilija (58843670200) ;Stojanović-Tasić, Mirjana (56301524700) ;Novaković, Tatjana (24352838100) ;Dutina, Aleksandra (57191286001) ;Bukumirić, Zoran (36600111200)Stašević-Karličić, Ivana (57191282121)Introduction/Objective Higher rates of morbidity and mortality from the infection of COVID-19 have been recorded among people with mental disorders, especially among those suffering from severe forms, so they should be prioritized during vaccination campaigns. The aim of this study was to examine possible predictors of acceptance of vaccination against COVID-19 in patients with mental disorders. Methods This retrospective study was conducted from January 2021 until January 2022 and included 458 patients with mental disorders treated at the Dr Laza Lazarević Clinic for Mental Disorders in Belgrade, Serbia. Patients were segregated into the vaccinated and the unvaccinated group depending on their vaccination status. A questionnaire developed specifically for the present study was administered to gather the participants’ sociodemographic characteristics, while data related to their mental disorders, COVID-19 infection, and comorbidities was obtained from their medical records. Results Eighty percent of the vaccinated group opted for the Sinopharm vaccine. Significantly higher percentage of vaccinated patients was hospitalized during the study period and had comorbidities compared to the unvaccinated group (51.4% vs. 32.6% and 52.8% vs. 37.5%, respectively). Education level, employment status, marital status, diagnostic category, and comorbidities were statistically significant predictors of COVID-19 vaccination uptake among people with mental disorders. Conclusion Our findings show that higher level of education, greater trust in the healthcare system, and knowledge of the available vaccination points significantly contribute to the vaccination uptake in this vulnerable population group. © 2024, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication The first prevalence study of primary headaches in adults in a post-conflict area of Serbia(2021) ;Milošević, Nenad (57201272649) ;Trajković, Jasna Zidverc (55985785700) ;Mijajlović, Milija (55404306300) ;Milošević, Jovana (56954533100) ;Podgorac, Ana (55587430800) ;Vitošević, Zdravko (9232864200) ;Novaković, Tatjana (24352838100)Pekmezović, Tatjana (7003989932)Aim: The aim of the present study was to establish annual prevalence of primary headaches, migraine, and tension-type headache among adults in a post-conflict area of Serbia. Methods: The data for this cross-sectional study was obtained via face-to-face interviews using questionnaires specifically designed for this purpose, in line with the available guidelines. The study sample included adults aged 18–65 years whose native language is Serbian with residence in six predominantly Serbian communities in Kosovo and Metohija. Relevant diagnoses were established according to the diagnostic criteria of the International Classification of Headache Disorders, 3rd edition. Results: The study included 1062 adults. Analyses indicated 47.7% prevalence of primary headaches. The 1-year prevalence of migraine (with aura and without aura) and tension-type headache was established at 15.2% (3.3% and 11.9%), and 32.2%, respectively. One-year prevalence of chronic headache was calculated at 3.5%, while the prevalence of medication overuse headache was slightly lower at 2.9%. Primary headaches were more prevalent among women, participants residing south of the river Ibar, married or cohabiting individuals, as well as among interviewees (persons) who reported feeling unsafe in Kosovo and Metohija. This is the first study of the prevalence of primary headache disorders in Serbia. The obtained data is comparable to the data available for other countries, especially those in the Balkan region. © International Headache Society 2021. - Some of the metrics are blocked by yourconsent settings
Publication The impact of changes in psoriasis area and severity index by body region on quality of life in patients with psoriasis(2017) ;Sojević Timotijević, Zorica (55901969300) ;Majcan, Predrag (55826837300) ;Trajković, Goran (9739203200) ;Relić, Milijana (55484461500) ;Novaković, Tatjana (24352838100) ;Mirković, Momčilo (37048783100) ;Djurić, Sladjana (37048654200) ;Nikolić, Simon (56111872000) ;Lazić, Bratislav (57193686011)Janković, Slavenka (7101906308)Psoriasis severity varies by body region, with each affected region having a different impact on patient quality of life (QoL). The aim of this study was to assess the impact of changes in the Psoriasis Area and Severity Index (PASI) scores by body region on QoL in patients with psoriasis after treatment. A total of 100 patients with psoriasis were recruited to the study. All patients completed the generic EuroQol-5D instrument and two specific QoL measures, Dermatology Life Quality Index (DLQI) and Psoriasis Disability Index (PDI) at the beginning of the study, and 50 patients successfully completed the same questionnaires four weeks after the end of the treatment. Clinical severity was assessed using PASI total score and PASI body region (head, trunk, arms, and legs) scores. QoL improved after treatment, and PASI improvements on visible body regions (head, legs, and arms) showed significant correlation with the most sub-areas of the Visual Analog Scale (EQ VAS), DLQI, and PDI. Multiple linear regression analysis revealed that PASI improvement (particularly on the head), sex, age, and disease duration were predictors of QoL score changes for most domains of the three instruments. Improvement of psoriasis in visible body regions has an appreciable influence on QoL improvement, and may positively affect treatment success in patients with psoriasis. © 2017, Croatian Dermatovenerological Society. All rights reserved.
